Search - Archive ouverte HAL Access content directly

Filter your results

61 Results
authIdHal_s : anne-quillet-mary
Image document

Lymphoma Heterogeneity Unraveled by Single-Cell Transcriptomics

Loic Ysebaert , Anne Quillet-Mary , Marie Tosolini , Frederic Pont , Camille Laurent et al.
Frontiers in Immunology, 2021, 12, pp.597651. ⟨10.3389/fimmu.2021.597651⟩
Journal articles hal-03153258v1

Target lysis by human lak cells is critically dependent upon target binding properties, but LFA-1, LFA-3 AND ICAM-1 are not the major adhesion ligands on targets

Anne Quillet-Mary , Laurent Cavarec , Nathalie Kermarrec , Carmen Marchiol-Fournigault , Maria Luisa Gil et al.
International Journal of Cancer, 1991, 47 (3), pp.473-479. ⟨10.1002/ijc.2910470328⟩
Journal articles hal-02349227v1

Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment

S Betrian , Loic Ysebaert , K Heider , J. P Delord , J Fournié et al.
Blood Cancer Journal, 2016, 6 (11), pp.e496-e496. ⟨10.1038/bcj.2016.106⟩
Journal articles hal-02348641v1
Image document

Population Pharmacokinetics of Ibrutinib and Its Dihydrodiol Metabolite in Patients with Lymphoid Malignancies

Fanny Gallais , Loic Ysebaert , Fabien Despas , Sandra de Barros , Loïc Dupré et al.
Clinical Pharmacokinetics, 2020, 59 (9), pp.1171-1183. ⟨10.1007/s40262-020-00884-0⟩
Journal articles hal-02989879v1

DNA polymerase ν gene expression influences fludarabine resistance in chronic lymphocytic leukemia independently of p53 status

Srdana Grgurevic , Patricia Montilla-Perez , Alice Bradbury , Julia Gilhodes , Sophie Queille et al.
Haematologica, 2018, 103 (6), pp.1038-1046. ⟨10.3324/haematol.2017.174243⟩
Journal articles hal-02347541v1

Daunorubicin-induced internucleosomal DNA fragmentation in acute myeloid cell lines.

A Quillet-Mary , V Mansat , E Duchayne , M Come , M Allouche et al.
Leukemia, 1996, 10 (3), pp.417-25
Journal articles hal-02349188v1

Protein kinase C ζ associates with death inducing signaling complex and regulates Fas ligand-induced apoptosis

Ingrid Leroy , Aurélie de Thonel , Guy Laurent , Anne Quillet-Mary
Cellular Signalling, 2005, 17 (9), pp.1149-1157. ⟨10.1016/j.cellsig.2004.12.013⟩
Journal articles istex hal-02349056v1

Rituximab inhibits B-cell receptor signaling

Samar Kheirallah , Pierre Caron , Emilie Gross , Anne Quillet-Mary , Justine Bertrand-Michel et al.
Blood, 2010, 115 (5), pp.985-994. ⟨10.1182/blood-2009-08-237537⟩
Journal articles hal-03477044v1
Image document

PKCzeta protects against UV-C-induced apoptosis by inhibiting acid sphingomyelinase-dependent ceramide production

Alexandra Charruyer , Christine Jean , Audrey Colomba , Jean-Pierre Jaffrézou , Anne Quillet-Mary et al.
Biochemical Journal, 2007, 405 (1), pp.77-83. ⟨10.1042/BJ20061528⟩
Journal articles hal-00478682v1

Daunorubicin- and Mitoxantrone-Triggered Phosphatidylcholine Hydrolysis: Implication in Drug-Induced Ceramide Generation and Apoptosis

Ali Bettaieb , Isabelle Plo , Véronique Mansat-de Mas , Anne Quillet-Mary , Thierry Levade et al.
Molecular Pharmacology, 1999, 55 (1), pp.118-125. ⟨10.1124/mol.55.1.118⟩
Journal articles hal-02349169v1
Image document

Phased differentiation of γδ T and T CD8 tumorinfiltrating lymphocytes revealed by single-cell transcriptomics of human cancers

Juan-Pablo Cerapio , Marion Perrier , Camille-Charlotte Balança , Pauline Gravelle , Fréderic Pont et al.
OncoImmunology, In press, ⟨10.1080/2162402X.2021.1939518⟩
Journal articles hal-03365502v1
Image document

Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapse

Sarah Cadot , Carine Valle , Marie Tosolini , Frederic Pont , Laetitia Largeaud et al.
Biomarker Research, 2020, 8 (1), ⟨10.1186/s40364-020-00253-w⟩
Journal articles hal-03081383v1

TNFα stimulates NKG2D-mediated lytic activity of acute myeloid leukemic cells

F Guilloton , A. de Thonel , C Jean , C. Demur , V Mansat-de Mas et al.
Leukemia, 2005, 19 (12), pp.2206-2214. ⟨10.1038/sj.leu.2403952⟩
Journal articles hal-02349023v1

Abstract 2852: Obinutuzumab (GA101) efficacy in chronic lymphocytic leukemia in vitro is not diminished in high risk patients.

Loic Ysebaert , Emilie Laprevotte , Christian Klein , Jean-Jacques Fournié , Anne Quillet-Mary et al.
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC, Apr 2013, Washington, United States. pp.2852-2852, ⟨10.1158/1538-7445.AM2013-2852⟩
Conference papers hal-02348799v1

Endogenous IL-8 acts as a CD16 co-activator for natural killer-mediated anti-CD20 B cell depletion in chronic lymphocytic leukemia

Emilie Laprevotte , Loic Ysebaert , Christian Klein , Wilfried Valleron , Amandine Blanc et al.
Leukemia Research, 2013, 37 (4), pp.440-446. ⟨10.1016/j.leukres.2012.11.015⟩
Journal articles hal-02348811v1
Image document

Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancers

Juan-Pablo Cerapio , Marion Perrier , Camille-Charlotte Balança , Pauline Gravelle , Fréderic Pont et al.
OncoImmunology, 2021, 10 (1), ⟨10.1080/2162402X.2021.1939518⟩
Journal articles hal-03363714v1

An improved double fluorescence flow cytometry method for the quantification of killer cell/target cell conjugate formation

Laurent Cavarec , Anne Quillet-Mary , Didier Fradelizi , Hélène Conjeaud
Journal of Immunological Methods, 1990, 130 (2), pp.251-261. ⟨10.1016/0022-1759(90)90055-Z⟩
Journal articles istex hal-02349237v1
Image document

S141: Eliciting anti-tumor t cell activity in chronic lymphocytic leukemia with bispecific antibody-based combination therapy

Despoina Papazoglou , Loic Ysebaert , Nikolaos Ioannou , Benedetta Apollonio , Piers Patten et al.
HemaSphere, 2022, 6, pp.42-43. ⟨10.1097/01.hs9.0000843456.05456.f5⟩
Journal articles hal-03795600v1

Ibrutinib Exposure and B-Cell Depletion Induced By Anti-CD20 Monoclonal Antibodies Rituximab and Obinutuzumab: Is There a Rationale for Combination Studies?

Loic Ysebaert , Christian Klein , Anne Quillet-Mary
Blood, 2014, 124 (21), pp.1980-1980. ⟨10.1182/blood.V124.21.1980.1980⟩
Journal articles hal-02348895v1

Overexpression of Protein Kinase Cζ Confers Protection Against Antileukemic Drugs by Inhibiting the Redox-Dependent Sphingomyelinase Activation

Christine Bezombes , Aurélie de Thonel , Andriana Apostolou , Thierry Louat , Jean-Pierre Jaffrézou et al.
Molecular Pharmacology, 2002, 62 (6), pp.1446-1455. ⟨10.1124/mol.62.6.1446⟩
Journal articles hal-03030310v1

Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia

Ian Flinn , John Gribben , Martin Dyer , William Wierda , Michael Maris et al.
Blood, 2019, 133 (26), pp.2765-2775. ⟨10.1182/blood-2019-01-896290⟩
Journal articles hal-02324667v1

Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes

Gabriele Pizzolato , Hannah Kaminski , Marie Tosolini , Don-Marc Franchini , Fréderic Pont et al.
Proceedings of the National Academy of Sciences of the United States of America, 2019, 116 (24), pp.11906-11915. ⟨10.1073/pnas.1818488116⟩
Journal articles hal-02315851v1

Clinical and Biological Characteristics Associated with In Vitro Activity of Anti-CD20 Monoclonal Antibodies, Rituximab and GA101, Against Chronic Lymphocytic Leukemia Cells

Loic Ysebaert , Emilie Laprévotte , Christian Klein , Guy Laurent , Jean-Jacques Fournié et al.
Blood, 2010, 116 (21), pp.2459-2459. ⟨10.1182/blood.V116.21.2459.2459⟩
Journal articles hal-02348933v1

Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies

Julie Gertner , Cecile Bonnafous , Christine Bezombes , Aude-Hélène Capietto , Virginie Scaglione et al.
Blood, 2009, 113 (20), pp.4875-4884. ⟨10.1182/blood-2008-08-172296⟩
Journal articles hal-02348974v1

2.27 Differential Gene Expression and Secretory Profiles of Nurse-like Cells Specifically Derived from Chronic Lymphocytic Leukemia Help Decipher New Pathways to Pathogenesis

Loic Ysebaert , Yovan Sanchez-Ruiz , Nais Prade , Jean-Philippe Guégan , Anne Quillet-Mary et al.
Clinical Lymphoma Myeloma and Leukemia, 2011, 11, pp.S175-S176. ⟨10.1016/j.clml.2011.09.060⟩
Journal articles istex hal-02348920v1
Image document

Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia

Martin Gauthier , Françoise Durrieu , Elodie Martin , Michael Peres , François Vergez et al.
BMC Cancer, 2019, 19 (1), pp.809. ⟨10.1186/s12885-019-5971-z⟩
Journal articles inserm-02296779v1

3R gene expression in chronic lymphocytic leukemia reveals insight into disease evolution

S Grgurevic , L Berquet , A Quillet-Mary , G. Laurent , C. Récher et al.
Blood Cancer Journal, 2016, 6 (6), pp.e429-e429. ⟨10.1038/bcj.2016.39⟩
Journal articles hal-02348653v1

Protein phosphatase-2A activation is a critical step for enzastaurin activity in chronic lymphoid leukemia cells

Cecile Liffraud , Anne Quillet-Mary , Jean-Jacques Fournié , Guy Laurent , Loic Ysebaert et al.
Leukemia & lymphoma, 2012, 53 (5), pp.966-972. ⟨10.3109/10428194.2011.634041⟩
Journal articles hal-02348823v1

Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapse

Sarah Cadot , Carine Valle , Marie Tosolini , Frederic Pont , Laetitia Largeaud et al.
Biomarker Research, 2020, 8 (1), ⟨10.1186/s40364-020-00253-w⟩
Journal articles hal-03365419v1

Rituximab inhibits B-cell receptor signaling

Samar Kheirallah , Pierre Caron , Emilie Gross , Anne Quillet-Mary , Justine Bertrand-Michel et al.
Blood, 2010, 115 (5), pp.985-994. ⟨10.1182/blood-2009-08-237537⟩
Journal articles hal-02348969v1